scienceNov 19, 202456:49pending
Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
About this episode
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Hope S Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center discuss treatment decision-making for HR-positive metastatic breast cancer in patients who harbor PI3K/AKT/PTEN pathway mutations.
Get every episode summarized
Each time Breast Cancer Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Breast Cancer Update
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and...
Breast Cancer Update
Mar 18, 202630:21failed
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Breast Cancer Update
Mar 16, 202616:43failed
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant N...
Breast Cancer Update
Mar 2, 202658:40pending
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San A...
Breast Cancer Update
Jan 27, 20262:01:07pending